Primer: Anavex Life Sciences (AVXL US) - Nov 2025
Anavex Life Sciences is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for central nervous system...
210 Views
Spotlight on Neurodegenerative Diseases: Innovative Treatments: Blarcamesine
The most advanced of the DMTs under clinical development is blarcamesine for early-stage AD by Anavex Life Sciences (NASDAQ: AVXL).
224 Views
No more insights